Dr. Saul Rosenberg M.D.?
Update this Profile
Dr. Saul Rosenberg M.D., Hematologist (Blood Specialist)
We verify the medical license of each FindaTopDoc Verified Doctor to ensure that their license is active and they are in good medical standing.

Dr. Saul Rosenberg M.D.

Hematologist-Oncologist | Hematology & Oncology

5/5(4)
269 Campus Dr Stanford CA, 94305
Rating

5/5

About

Dr. Saul Rosenberg is a hematologist oncologist practicing in Stanford, CA. Dr. Rosenberg specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.

Board Certification

Internal MedicineAmerican Board of Internal MedicineABIM

Internal MedicineAmerican Board of Internal MedicineABIM- Medical Oncology- 1973

Provider Details

MaleEnglish

Fellowships

  • Memorial Sloan - Kettering Cancer Center   1958

Publications

  • ANLS OF ONCOLOGYEfficacy of abbreviated Stanford V chemotherapy2013
  • JOURL OF CLINICAL ONCOLOGYRisk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma2013
  • INTERTIOL JOURL OF RADIATION ONCOLOGY BIOLOGY PHYSICSSTAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS2011
  • LEUKEMIA & LYMPHOMARare presentation of classical Hodgkin lymphoma with a clol T2010
  • ONCOLOGY RESEARCHDymic CD8 T-Cell Responses to Tumor2009
  • JOURL OF CLINICAL ONCOLOGYLymphography: A Great Advance, Abandoned2008
  • JOURL OF CLINICAL ONCOLOGYFollicular lymphoma revisited2008
  • JOURL OF CLINICAL ONCOLOGYImpact of positive positron emission tomography on prediction of freedom from progression after2007
  • ANLS OF HEMATOLOGYSplenic diffuse large B-cell lymphoma in a patient with type 1 Gaucher disease2006
  • JOURL OF CLINICAL ONCOLOGYStage I and II follicular non-Hodgkin's lymphoma: Long-term follow-up of no initial therapy2004
  • JOURL OF CLINICAL ONCOLOGYStanford V and radiotherapy for locally extensive and advanced Hodgkin's disease2002
  • ANLS OF ONCOLOGYTreatment of multicentric Castleman's disease complicated by the development of non1999
  • JOURL OF CLINICAL ONCOLOGYStanford-Kaiser permanente G1 study for clinical stage I to IIA Hodgkin's disease1997
  • BLOODComparison between conventiol salvage therapy1997
  • ANLS OF ONCOLOGYThe magement of Hodgkin's disease: Half a century of change - The Kaplan Memorial Lecture1996
  • JOURL OF CLINICAL ONCOLOGYBRIEF CHEMOTHERAPY, STANFORD-V1995
  • Current opinion in oncologyModern combined modality magement of Hodgkin's disease.1994
  • Anls of oncologyThe treatment of Hodgkin's disease.1994
  • ANLS OF ONCOLOGYTHE STANFORD EXPERIENCE WITH COMBINED PROCARBAZINE1992
  • EUROPEAN JOURL OF CANCERREDUCING THE TOXICITY OF THE COMBINED MODALITY THERAPY OF FAVORABLE STAGE HODGKINS-DISEASE1992
  • JOURL OF CLINICAL ONCOLOGYPROGNOSTIC INDICATORS OF LAPAROTOMY FINDINGS IN CLINICAL STAGE-I1989
  • JOURL OF CLINICAL ONCOLOGYVINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE1988
  • ANLS OF INTERL MEDICINEINTERCURRENT DEATH AFTER HODGKIN DISEASE THERAPY IN RADIOTHERAPY AND ADJUVANT MOPP TRIALS1988
  • JOURL OF CLINICAL ONCOLOGYEXPLORATORY LAPAROTOMY AND SPLENECTOMY FOR HODGKINS-DISEASE - A COMMENTARY1988
  • BloodImprovements in observed and relative survival in follicular grade 1-2 lymphoma during 4 decades2013
  • ANNALS OF ONCOLOGYEfficacy of abbreviated Stanford V chemotherapy2013
  • JOURNAL OF CLINICAL ONCOLOGYRisk of Therapy-Related Secondary Leukemia in Hodgkin Lymphoma2013
  • INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICSSTAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS2011
  • LEUKEMIA & LYMPHOMARare presentation of classical Hodgkin lymphoma with a clonal T2010
  • ONCOLOGY RESEARCHDynamic CD8 T-Cell Responses to Tumor2009
  • JOURNAL OF CLINICAL ONCOLOGYLymphography: A Great Advance, Abandoned2008
  • JOURNAL OF CLINICAL ONCOLOGYFollicular lymphoma revisited2008
  • JOURNAL OF CLINICAL ONCOLOGYImpact of positive positron emission tomography on prediction of freedom from progression after2007
  • ANNALS OF HEMATOLOGYSplenic diffuse large B-cell lymphoma in a patient with type 1 Gaucher disease2006
  • JOURNAL OF CLINICAL ONCOLOGYStage I and II follicular non-Hodgkin's lymphoma: Long-term follow-up of no initial therapy2004
  • JOURNAL OF CLINICAL ONCOLOGYStanford V and radiotherapy for locally extensive and advanced Hodgkin's disease2002
  • BLOODHigh-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first2001
  • ANNALS OF ONCOLOGYTreatment of multicentric Castleman's disease complicated by the development of non1999
  • JOURNAL OF CLINICAL ONCOLOGYStanford-Kaiser permanente G1 study for clinical stage I to IIA Hodgkin's disease1997
  • BLOODComparison between conventional salvage therapy1997
  • ANNALS OF ONCOLOGYThe management of Hodgkin's disease: Half a century of change - The Kaplan Memorial Lecture1996
  • Horning, S. J., Rosenberg, S. A., Hoppe, R. T.Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease1996
  • JOURNAL OF CLINICAL ONCOLOGYBRIEF CHEMOTHERAPY, STANFORD-V1995
  • BLOODCLASSIFICATION OF LYMPHOID NEOPLASMS1994
  • Current opinion in oncologyModern combined modality management of Hodgkin's disease.1994
  • Annals of oncologyThe treatment of Hodgkin's disease.1994
  • ANNALS OF ONCOLOGYTHE STANFORD EXPERIENCE WITH COMBINED PROCARBAZINE1992
  • EUROPEAN JOURNAL OF CANCERREDUCING THE TOXICITY OF THE COMBINED MODALITY THERAPY OF FAVORABLE STAGE HODGKINS-DISEASE1992
  • Rosenberg, S. A.THE CONTINUING CHALLENGE OF HODGKINS-DISEASE1991
  • BLOODCEPP(B) - AN EFFECTIVE AND WELL-TOLERATED REGIMEN IN POOR-RISK, AGGRESSIVE NON-HODGKINS-LYMPHOMA1990
  • CANCER RESEARCHHODGKINS-DISEASE - CHALLENGES FOR THE FUTURE1989
  • JOURNAL OF CLINICAL ONCOLOGYPROGNOSTIC INDICATORS OF LAPAROTOMY FINDINGS IN CLINICAL STAGE-I1989
  • Recent results in cancer research. Fortschritte der Krebsforschung. PrCurrent Stanford clinical trials for Hodgkin's disease.1989
  • JOURNAL OF CLINICAL ONCOLOGYVINBLASTINE, BLEOMYCIN, AND METHOTREXATE - AN EFFECTIVE ADJUVANT IN FAVORABLE HODGKINS-DISEASE1988
  • ANNALS OF INTERNAL MEDICINEINTERCURRENT DEATH AFTER HODGKIN DISEASE THERAPY IN RADIOTHERAPY AND ADJUVANT MOPP TRIALS1988
  • JOURNAL OF CLINICAL ONCOLOGYEXPLORATORY LAPAROTOMY AND SPLENECTOMY FOR HODGKINS-DISEASE - A COMMENTARY1988

Dr. Saul Rosenberg M.D.'s Practice location

Practice At 269 Campus Dr

269 Campus Dr -
Stanford, CA 94305
Get Direction
New patients: 650-853-2905, 650-725-6455
Fax: 650-853-2966

Dr. Saul Rosenberg M.D.'s reviews

(4)
Write Review

Patient Experience with Dr. Rosenberg


5.0

Based on 4 reviews

Dr. Saul Rosenberg M.D. has a rating of 5 out of 5 stars based on the reviews from 4 patients. FindaTopDoc has aggregated the experiences from real patients to help give you more insights and information on how to choose the best Hematologist-Oncologist in your area. These reviews do not reflect a providers level of clinical care, but are a compilation of quality indicators such as bedside manner, wait time, staff friendliness, ease of appointment, and knowledge of conditions and treatments.

Recommended Articles

  • Teen Finds Strength to Give Back After Battling Lymphoma

    Ayden Mills is a 14-year-old middle school student residing in Vancouver, Washington. It’s easy to wonder how someone could be an inspiration at such a young age, but what Mills has gone fought through is nothing short of amazing. Mills’s story shows how it is possible to fight through even the...

  • Facts About Multiple Myeloma

    Multiple myeloma is a certain form of cancer of the plasma cell, which is part of the immune system. It initiates in the bone marrow, where the blood cells are produced.The immune system is made of variety of cells that fight infections and keep the body healthy. What takes place in bone marrow...

  • John Quinones Teams Up With Survivors For Leukemia and Lymphoma Society

    Many cancer patients suffer in silence, with the public being largely unaware of the different types of cancer and how they affect patients. Most people obviously know that cancer is well, a bad thing, but there is a lot of nuance and important information that is lost on the common citizen. Most...

  • The Lymphoma Research Foundation's Light it Red for Lymphoma Night

    Lymphoma, a cancer of the lymphatic system, currently affects over 700,000 Americans who are living with or in remission from the disease. Statistics show that every seven minutes, someone in the United States is diagnosed with the condition, which amounts to approximately 80,000 people per year.The...

  • Breaking News on the Treatment of Follicular Lymphoma

    Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...

  • Tips on How to Live with Multiple Myeloma

    Multiple myeloma, a type of cancer, adversely affects plasma cells, which are your immune system’s components. The American Cancer Society indicates that in 2014, more than 24,000 people in the United States had multiple myeloma.Multiple myeloma patients can lose their appetite due to the adverse...

Nearby Providers

Nearest Hospitals

STANFORD HEALTH CAREl

300 PASTEUR DRIVE STANFORD CA 94305

Head east 199 ft
Turn right 341 ft
Turn right onto Campus Drive 983 ft
Turn right onto Welch Road 1105 ft
Turn right onto Pasteur Drive 55 ft
You have arrived at your destination, on the left

LUCILE SALTER PACKARD CHILDREN'S HSP AT STANFORDl

725 WELCH ROAD PALO ALTO CA 94304

Head east 199 ft
Turn right 341 ft
Turn right onto Campus Drive 983 ft
Turn right onto Welch Road 3150 ft
Turn right 348 ft
Turn left 69 ft
You have arrived at your destination, on the left

MENLO PARK SURGICAL HOSPITALl

570 WILLOW ROAD MENLO PARK CA 94025

Head east 199 ft
Turn right 384 ft
Turn left onto Campus Drive 3370 ft
Turn left onto Palm Drive 2931 ft
Continue straight onto University Avenue 851 ft
Continue onto University Avenue 3088 ft
Turn left onto Middlefield Road 2535 ft
Turn right onto Willow Road 3026 ft
Turn right 219 ft
You have arrived at your destination, on the right